Reactogenicity and immunogenicity of measles-rubella combined vaccine in school-entry-aged subjects with naturally acquired measles immunity

Pediatr Int. 2015 Aug;57(4):597-602. doi: 10.1111/ped.12596. Epub 2015 Apr 28.

Abstract

Background: The reintroduction of measles-rubella combined (MR) vaccination to Japan raised concerns about adverse events as well as immunogenicity related to booster immunization in subjects with naturally acquired immunity to measles or rubella.

Methods: The time course of reactogenicity and antibody responses in recipients with pre-existing immunity to measles through natural infection was observed. Eighteen children aged 80-104 months received MR booster vaccination; 16 of them had had previous rubella vaccination.

Results: There were virtually no clinical reactions related to booster vaccination, and a highly significant antibody response to rubella antigen, whereas the antibody rise to measles was statistically significant but poor.

Conclusions: Vaccination of individuals already immune is not harmful. Booster immunization to rubella for Japanese children is vitally important.

Keywords: antibody; measles-rubella combined vaccine; reactogenicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Anti-Idiotypic / immunology*
  • Child
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunity, Innate*
  • Immunoglobulin G / immunology*
  • Incidence
  • Japan / epidemiology
  • Male
  • Measles / epidemiology
  • Measles / prevention & control*
  • Measles-Mumps-Rubella Vaccine / pharmacology*
  • Mumps / epidemiology
  • Mumps / prevention & control*
  • Retrospective Studies
  • Rubella / epidemiology
  • Rubella / prevention & control*
  • Schools
  • Vaccination / methods

Substances

  • Antibodies, Anti-Idiotypic
  • Immunoglobulin G
  • Measles-Mumps-Rubella Vaccine